ZURICH/LONDON, Jan 12 (Reuters) - Swiss drugmaker Roche reaffirmed its dividend policy on Monday, dismissing talk it might sacrifice payouts to help fund a sweetened offer for the remainder of U.S. biotech giant Genentech.
ZURICH/LONDON, Jan 12 (Reuters) - Swiss drugmaker Roche reaffirmed its dividend policy on Monday, dismissing talk it might sacrifice payouts to help fund a sweetened offer for the remainder of U.S. biotech giant Genentech.
